Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-07-1501PMID 17909071PMCID PMC3622247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fanconi Anemia

  2019cited by this paper
• Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

  2007influential reference
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007influential reference
• A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

  2007cited by this paper
• FANCI is a second monoubiquitinated member of the Fanconi anemia pathway

  2007influential reference
• FANCD2 associated with sporadic breast cancer risk.

  2006cited by this paper
• Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

  2006influential reference
• Molecular pathogenesis of Fanconi anemia: recent progress.

  2006cited by this paper
• Fanconi anaemia genes and susceptibility to cancer

  2006cited by this paper
• Fanconi anemia.

  2006cited by this paper
• Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair*

  2006cited by this paper
• Molecular cross-talk among chromosome fragility syndromes.

  2004cited by this paper
• American Association for Cancer Research

  2004cited by this paper
• Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice

  2004cited by this paper
• Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients

  2004cited by this paper
• Spectrum of sequence variations in the FANCA gene: An International Fanconi Anemia Registry (IFAR) study

  2003cited by this paper
• A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

  2003cited by this paper
• Validation of self-reported cancers in the California Teachers Study.

  2003cited by this paper
• Cancer in Fanconi anemia, 1927–2001

  2003cited by this paper
• Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.

  2003cited by this paper
• Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

  2003cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool.

  2002cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.

  2001cited by this paper
• Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

  2001cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• High frequency of large intragenic deletions in the Fanconi anemia group A gene.

  1999cited by this paper
• Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults.

  1998cited by this paper
• Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia.

  1998cited by this paper
• Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study.

  1997cited by this paper
• Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.

  1995cited by this paper
• Fanconi anemia diagnosis and the diepoxybutane (DEB) test.

  1993cited by this paper
• Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

  1987cited by this paper
• Statistical methods in cancer research. IARC Workshop 25-27 May 1983.

  1987cited by this paper
• Cancer in relatives of patients with aplastic anemia.

  1983cited by this paper
• Fanconi's Anaemia in the Genetics of Neoplasia

  1971cited by this paper
• The incidence of leukemia in families of patients with hypoplasia of the marrow.

  1959cited by this paper
• Cancer in Fanconi Anemia

  year unknowncited by this paper

• The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers

  2026cites this paper
• Germline Testing in Hematopoietic Malignancies

  2025cites this paper
• Heterozygous Germline Fanconi Anemia–Related Gene Mutations Increase Susceptibility to Germ Cell Tumors

  2025cites this paper
• Prediction of Cancer Proneness under Influence of X-rays with Four DNA Mutability and/or Three Cellular Proliferation Assays

  2024cites this paper
• Germline variants in acquired aplastic anemia: current knowledge and future perspectives

  2024cites this paper
• First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants

  2024cites this paper
• Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy

  2024cites this paper
• In Reply to Rivers et al.

  2024cites this paper
• Grade 5 Radiation Necrosis After Whole-Brain Radiation Therapy.

  2024cites this paper
• Liver abnormalities are frequent and persistent in patients with Fanconi anemia

  2024cites this paper
• Most Fanconi anemia heterozygotes are not at increased cancer risk: a genome-first DiscovEHR cohort population study.

  2023cites this paper
• Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer

  2023cites this paper
• Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma

  2023cites this paper
• Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene

  2023cites this paper
• Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy.

  2022cites this paper
• Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms

  2022cites this paper
• A cross-sectional survey of genetic counselors providing carrier screening regarding GBA variants and Parkinson disease susceptibility

  2022cites this paper
• Application of Multigene Panels Testing for Hereditary Cancer Syndromes

  2022cites this paper
• Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability

  2022cites this paper
• XRCC2 reduced the sensitivity of NSCLC to radio-chemotherapy by arresting the cell cycle.

  2022cites this paper
• Risk of cancer in heterozygous relatives of patients with Fanconi anemia.

  2021cites this paper
• Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients.

  2021cites this paper
• Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

  2021cites this paper
• Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature

  2021cites this paper
• Diagnosis of Fanconi Anemia: Testing and Genetic Counseling

  2021cites this paper
• Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies

  2021cites this paper
• Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes

  2020cites this paper
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

  2020cites this paper
• Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.

  2020cites this paper
• Analysis of Rare Variant c.2395C>T (p.Arg799Trp) in Gene ERCC4 in Breast Cancer Patients from Bashkortostan

  2020cites this paper
• Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia

  2020cites this paper
• Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

  2020cites this paper
• Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients

  2020cites this paper
• Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report

  2019cites this paper
• Prenatal genetic counselors' practices and confidence level when counseling on cancer risk identified on expanded carrier screening

  2019cites this paper
• Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA1/2-Negative Chinese Familial Breast and/or Ovarian Cancer Patients

  2019cites this paper
• Rothmund–Thomson Syndrome, Bloom Syndrome, Dyskeratosis Congenita, Fanconi Anaemia and Poikiloderma with Neutropenia

  2019cites this paper
• Quick glance at Fanconi anemia and BRCA2/FANCD1

  2019cites this paper
• Two truncating variants in FANCC and breast cancer risk

  2019cites this paper
• Inherited variants in XRCC2 and the risk of breast cancer

  2019cites this paper
• Rare variants in FANCA induce premature ovarian insufficiency

  2019cites this paper
• Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia

  2018cites this paper
• Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility

  2018cites this paper
• Hematological Malignancies in Adults With a Family Predisposition.

  2018cites this paper
• Fanconi anaemia and cancer: an intricate relationship

  2018cites this paper
• Hämatologische Neoplasien im Erwachsenenalter mit familiärer Prädisposition

  2018cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology FANCC ( Fanconi anaemia complementation group C )

  2018cites this paper
• Chromosome instability syndromes

  2018cites this paper
• Fanconi Anemia Signaling: The Role of FANCD2 During M Phase.

  2018cites this paper
• Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility

  2017cites this paper
• Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML

  2017cites this paper
• The genomics of inherited bone marrow failure: from mechanism to the clinic

  2017cites this paper
• Measurement of sensitivity to DNA damaging agents

  2017cites this paper
• Identification of novel risk variants for sarcoma and other cancers by whole exome sequencing analysis in cancer cluster families

  2017cites this paper
• Interplay between Fanconi anemia and homologous recombination pathways in genome integrity

  2016cites this paper
• Breast Cancer Genetics for the Surgeon: An Update on Causes and Testing Options.

  2016cites this paper
• MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

  2016cites this paper
• Defects in homologous recombination repair behind the human diseases: FA and HBOC.

  2016cites this paper
• The Fanconi Anemia Pathway and Interstrand Cross-Link Repair

  2016cites this paper
• Erratum to: Genetic Counselors’ Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels

  2016cites this paper
• Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene

  2016cites this paper
• Genetic Counselors’ Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels

  2016cites this paper
• Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network

  2016cites this paper
• Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults

  2015cites this paper
• AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia

  2015cites this paper
• Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer

  2015cites this paper
• Identification of novel hereditary cancer genes by whole exome sequencing.

  2015cites this paper
• Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.

  2015cites this paper
• Genetic Counseling for Fanconi Anemia: Crosslinking Disciplines

  2014cites this paper
• Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research.

  2014cites this paper
• Comparison of Chromosome Breakage in Non-Mosaic and Mosaic Patients with Fanconi Anemia, Relatives, and Patients with Other Inherited Bone Marrow Failure Syndromes

  2014cites this paper
• Global and disease-associated genetic variation in the human Fanconi anemia gene family.

  2014cites this paper
• The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.

  2014cites this paper
• Hereditary breast cancer: ever more pieces to the polygenic puzzle

  2013influential citation
• Fanconi anaemia and the repair of Watson and Crick DNA crosslinks

  2013cites this paper
• Impaired Effects of a FANCC Splicing Isoform in FANC-BRCA DNA Repair Pathway

  2013influential citation
• FANCC (Fanconi anaemia complementation group C)

  2013cites this paper
• Polymorphic variations in the FANCA gene in high‐risk non‐BRCA1/2 breast cancer individuals from the French Canadian population

  2013cites this paper
• The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?

  2013cites this paper
• Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles

  2012cites this paper
• Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing

  2012cites this paper
• Analyse des variants d'épissage du gène FANCC et leur impact sur la voie de réparation de l'ADN FANC-BRCA

  2012cites this paper
• Heterozygous Mutations in DNA Repair Genes and Hereditary Breast Cancer: A Question of Power

  2012cites this paper
• Biomarkers for genome instability in some genetic disorders: a pilot study

  2012cites this paper
• Rothmund–Thomson Syndrome, Bloom Syndrome, Dyskeratosis Congenita, Fanconi Anaemia

  2011cites this paper
• Analyse des variants de séquence et d'épissage du gène FANCC chez les familles canadiennes-françaises à risque élevé pour le cancer du sein et/ou de l'ovaire

  2011cites this paper
• Aplasies médullaires constitutionnelles

  2011cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011cites this paper
• Knockdown of FANCL may impair multi-lineage progenitor expansion from cord blood stem cells

  2011cites this paper
• DNA repair: the link between primary immunodeficiency and cancer

  2011cites this paper
• How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel

  2011cites this paper
• Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.

  2011cites this paper
• Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers

  2011cites this paper
• Phenotype-Genotype Correlation in Familial Breast Cancer

  2011cites this paper
• Fanconi Anemia/Brca Pathway and Head and Neck Squamous Cell Carcinomas

  2011cites this paper
• Open Access RESEARCH

  2010cites this paper
• Genetic Susceptibility and High Risk Groups for Pancreatic Cancer

  2010cites this paper
• Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents

  2010cites this paper
• Susceptibility pathways in Fanconi's anemia and breast cancer.

  2010cites this paper
• Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

  2010cites this paper